253 related articles for article (PubMed ID: 24828968)
1. Candidate metrics for evaluating the impact of prescriber education on the safe use of extended-release/long-acting (ER/LA) opioid analgesics.
Willy ME; Graham DJ; Racoosin JA; Gill R; Kropp GF; Young J; Yang J; Choi J; MaCurdy TE; Worrall C; Kelman JA
Pain Med; 2014 Sep; 15(9):1558-68. PubMed ID: 24828968
[TBL] [Abstract][Full Text] [Related]
2. Opioid tolerance and urine drug testing among initiates of extended-release or long-acting opioids in Food and Drug Administration's Sentinel System.
Larochelle MR; Cocoros NM; Popovic J; Dee EC; Kornegay C; Ju J; Racoosin JA
J Opioid Manag; 2017; 13(5):315-327. PubMed ID: 29199397
[TBL] [Abstract][Full Text] [Related]
3. Opioid prescribing in emergency departments: the prevalence of potentially inappropriate prescribing and misuse.
Logan J; Liu Y; Paulozzi L; Zhang K; Jones C
Med Care; 2013 Aug; 51(8):646-53. PubMed ID: 23632597
[TBL] [Abstract][Full Text] [Related]
4. Opioid prescribing practices in chronic pain management: guidelines do not sufficiently influence clinical practice.
Victor TW; Alvarez NA; Gould E
J Pain; 2009 Oct; 10(10):1051-7. PubMed ID: 19595639
[TBL] [Abstract][Full Text] [Related]
5. Assessing the impact of the extended-release/long-acting opioid an-algesics risk evaluation and mitigation strategies on opioid prescrip-tion volume.
Divino V; Cepeda MS; Coplan P; Maziere JY; Yuan Y; Wade RL
J Opioid Manag; 2017; 13(3):157-168. PubMed ID: 28829517
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Potentially Inappropriate Prescribing of Opioid Analgesics Requiring Prior Opioid Tolerance.
Jeffery MM; Chaisson CE; Hane C; Rumanes L; Tucker J; Hang L; McCoy R; Chen CL; Bicket MC; Hooten WM; Larochelle M; Becker WC; Kornegay C; Racoosin JA; Sanghavi D
JAMA Netw Open; 2020 Apr; 3(4):e202875. PubMed ID: 32293684
[TBL] [Abstract][Full Text] [Related]
7. Use of prescription opioids with abuse-deterrent technology to address opioid abuse.
Michna E; Kirson NY; Shei A; Birnbaum HG; Ben-Joseph R
Curr Med Res Opin; 2014 Aug; 30(8):1589-98. PubMed ID: 24738694
[TBL] [Abstract][Full Text] [Related]
8. Evolution of opioid risk management and review of the classwide REMS for extended-release/long-acting opioids.
Stanos S
Phys Sportsmed; 2012 Nov; 40(4):12-20. PubMed ID: 23306411
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Extended-Release/Long-Acting Opioid Prescribing Risk Evaluation and Mitigation Strategy Program by the US Food and Drug Administration: A Review.
Heyward J; Olson L; Sharfstein JM; Stuart EA; Lurie P; Alexander GC
JAMA Intern Med; 2020 Feb; 180(2):301-309. PubMed ID: 31886822
[TBL] [Abstract][Full Text] [Related]
10. Compliance with opioid treatment guidelines for chronic non-cancer pain (CNCP) in primary care at a Veterans Affairs Medical Center (VAMC).
Sekhon R; Aminjavahery N; Davis CN; Roswarski MJ; Robinette C
Pain Med; 2013 Oct; 14(10):1548-56. PubMed ID: 23746149
[TBL] [Abstract][Full Text] [Related]
11. SCOPE of Pain: An Evaluation of an Opioid Risk Evaluation and Mitigation Strategy Continuing Education Program.
Alford DP; Zisblatt L; Ng P; Hayes SM; Peloquin S; Hardesty I; White JL
Pain Med; 2016 Jan; 17(1):52-63. PubMed ID: 26304703
[TBL] [Abstract][Full Text] [Related]
12. Opioid epidemic in the United States.
Manchikanti L; Helm S; Fellows B; Janata JW; Pampati V; Grider JS; Boswell MV
Pain Physician; 2012 Jul; 15(3 Suppl):ES9-38. PubMed ID: 22786464
[TBL] [Abstract][Full Text] [Related]
13. Medical cost savings associated with an extended-release opioid with abuse-deterrent technology in the US.
Rossiter LF; Kirson NY; Shei A; White AG; Birnbaum HG; Ben-Joseph R; Michna E
J Med Econ; 2014 Apr; 17(4):279-87. PubMed ID: 24559196
[TBL] [Abstract][Full Text] [Related]
14. Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use.
Webster BS; Verma SK; Gatchel RJ
Spine (Phila Pa 1976); 2007 Sep; 32(19):2127-32. PubMed ID: 17762815
[TBL] [Abstract][Full Text] [Related]
15. Potential misuse and inappropriate prescription practices involving opioid analgesics.
Liu Y; Logan JE; Paulozzi LJ; Zhang K; Jones CM
Am J Manag Care; 2013 Aug; 19(8):648-658. PubMed ID: 24304213
[TBL] [Abstract][Full Text] [Related]
16. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States.
Cicero TJ; Surratt H; Inciardi JA; Munoz A
Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):827-40. PubMed ID: 17636553
[TBL] [Abstract][Full Text] [Related]
17. A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain.
Arora S; Setnik B; Michael D; Hudson JD; Clemmer R; Meisner P; Pixton GC; Goli V; Sommerville KW
J Opioid Manag; 2014; 10(6):423-36. PubMed ID: 25531960
[TBL] [Abstract][Full Text] [Related]
18. ER/LA opioid REMS and accredited education: Survey results provide insight into clinical roles, educational needs, and learner preferences.
Kear C; McKeithen T; Robertson S
Subst Abus; 2017; 38(2):145-149. PubMed ID: 28418777
[TBL] [Abstract][Full Text] [Related]
19. The impact of a reformulation of extended-release oxycodone designed to deter abuse in a sample of prescription opioid abusers.
Havens JR; Leukefeld CG; DeVeaugh-Geiss AM; Coplan P; Chilcoat HD
Drug Alcohol Depend; 2014 Jun; 139():9-17. PubMed ID: 24721614
[TBL] [Abstract][Full Text] [Related]
20. A statewide prescription monitoring program affects emergency department prescribing behaviors.
Baehren DF; Marco CA; Droz DE; Sinha S; Callan EM; Akpunonu P
Ann Emerg Med; 2010 Jul; 56(1):19-23.e1-3. PubMed ID: 20045578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
